Phase 3 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with moderately to severely active Ulcerative Colitis (UC) before the screening visit
- People whose UC affects areas beyond just the rectum, as confirmed by a camera examination of the bowel done at the start of the trial
- People whose UC has not responded well to at least one previous treatment, who have stopped responding to a treatment over time, or who were unable to tolerate at least one of the following: certain anti-inflammatory tablets (aminosalicylates), steroid medications, immune-suppressing medications, or biologic therapies
Who may not be able to join:
- People who have been diagnosed with Crohn's disease or a form of inflammatory bowel disease that doctors have been unable to clearly classify
- People who have tested positive for a harmful gut infection called Clostridioides difficile (a type of bacterial infection that affects the bowel)
- People who have had a specific blood-filtering procedure (apheresis) within 2 weeks before being assigned to a treatment group in the trial
- People who have a history of, or are currently living with, a condition where the immune system does not work properly, or people whose bowel condition is caused by a known genetic disorder
- There are additional eligibility criteria set out in the trial protocol that are not listed here (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Australian sites
0298453999
+61395943577
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Proportion of participants who achieve clinical remission
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.